XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Feb. 13, 2024
Dec. 11, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Jun. 15, 2023
Subsidiary, Sale of Stock [Line Items]            
Issue of shares of capital stock     400,000,000      
Common stock, shares authorized     300,000,000   300,000,000  
Preferred stock, shares authorized     100,000,000   100,000,000  
Reverse stock split   1-for-2.05        
Exercise price     $ 7.00      
Deferred finance costs         $ 5,950  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount     2,168,086 39,088    
Common Stock [Member]            
Subsidiary, Sale of Stock [Line Items]            
Issue of shares of capital stock       268,025    
IPO units, shares     1,000,000      
Bay Shore Trust [Member]            
Subsidiary, Sale of Stock [Line Items]            
Exercise price         $ 15.42 $ 3.73
Exercise price         $ 3.73  
Shares of common stock           2,439,025
IPO [Member]            
Subsidiary, Sale of Stock [Line Items]            
IPO units, shares 1,000,000          
Initial public offering shares $ 7.00          
Gross proceeds $ 7,000          
Underwriting commission and other offering expenses 1,200          
Initial public offering net proceeds $ 5,800          
IPO [Member] | Warrant [Member]            
Subsidiary, Sale of Stock [Line Items]            
IPO units, shares 50,000          
Private Placement [Member]            
Subsidiary, Sale of Stock [Line Items]            
Purchase of common stock       268,025 268,025  
Private Placement [Member] | Common Stock [Member]            
Subsidiary, Sale of Stock [Line Items]            
Purchase of common stock         67,007